Prolonged duration of response to infliximab in early pediatric Crohn's disease

J Pediatr Gastroenterol Nutr. 2001 Sep:33 Suppl 1:S40-3. doi: 10.1097/00005176-200109001-00007.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Child
  • Crohn Disease / drug therapy*
  • Follow-Up Studies
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Prospective Studies
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab